So-Young rethinks reverse share split as its stock surges
The cosmetic surgery specialist’s shares have nearly doubled in the last two weeks as investors flock to its new business model centered on self-operated clinics Key Takeaways: So-Young has delayed…
Kintor Pharma shifts from cancer drugs to cosmetics as funds run low
The cash-strapped biotech has begun generating its first revenue from over-the-counter cosmetic treatments, as it pivots away from its original oncology drugs Key Takeaways: Kintor Pharma is shifting from its…
BRIEF: Yonghe Medical’s loss narrows on improved efficiency
Hair transplant specialist Yonghe Medical Group Co. Ltd. (2279.HK) said on Tuesday it expects its net loss for 2024 to narrow significantly to 246 million yuan ($33.73 million) or less,…
Stock disconnect triggers investor exodus from CStone Pharma
The share price fell nearly 40% in a week after the drugs company was dropped from a scheme allowing mainland investors to trade Hong Kong-listed stocks Key Takeaways: CEO Jason…
Yonghe Medical’s share repurchase gets results, but can’t hide a receding profit line
A big run-up in wages and marketing costs related to its aggressive expansion pulled the hair restoration company into the red in the first half of this year Key Takeaways:…
FAST NEWS: Yonghe Medical swings to red, sending shares to new low
The latest: Hair transplant specialist Yonghe Medical Group Co. Ltd. (2279.HK) issued a profit warning last Friday, saying it expects a net loss of about 240 million yuan ($33.6 million) in the first half…
FAST NEWS: Yonghe Medical Expects Half-year Profit To Plunge 50% to 73%
The latest: Hair transplant specialist Yonghe Medical Group Co. Ltd. (2279.HK) issued a profit warning last last week, saying it expects a net profit of about 11 million yuan ($16.2 million) to…